Lead biomarkers and DNA methylation within retrotransposons Hu H, Shih R, Rothenberg S, Schwartz BS. 2007. The epidemiol- ogy of lead toxicity in adults: measuring dose and con- sideration of other methodologic issues. Environ Health Perspect 115:455–462. Issa JP. 2002. Epigenetic variation and human disease J Nutr 132:2388S–2392S. Kazazian HH Jr, Moran JV. 1998. The impact of L1 retrotrans- posons on the human genome. Nat Genet 19:19–24. Klose RJ, Bird AP. 2006. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31:89–97. Kosnett MJ, Wedeen RP, Rothenberg SJ, Hipkins KL, Materna BL, Schwartz BS, et al. 2007. Recommendations for medi- cal management of adult lead exposure. Environ Health Perspect 115:463–471. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860–921. Leggett RW. 1993. An age-specific kinetic model of lead metabo- lism in humans. Environ Health Perspect 101:598–616. Pilsner JR, Hu H, Ettinger A, Sánchez BN, Wright RO, Cantonwine D, et al. 2009. Influence of prenatal lead expo- sure on genomic methylation of cord blood DNA. Environ Health Perspect 117:1466–1471. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, et al. 2007. Genomic methylation of peripheral blood leuko- cyte DNA: influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr 86(4):1179–1186. Pogribny IP, Tryndyak VP, Woods CG, Witt SE, Rusyn I. 2007. Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha. Mutat Res 625(1–2):62–71. Reichard JF, Schnekenburger M, Puga A. 2007. Long term low-dose arsenic exposure induces loss of DNA methyla- tion. Biochem Biophys Res Commun 352:188–192. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al. 1998. Abdominal adiposity and coro- nary heart disease in women. JAMA 280:1843–1848. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Cervantes F, Sanchez J, Garate L, et al. 2005. Promoter hypomethyla- tion of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 24:7213–7223. Rosner B. 1983. Percentage points for a generalized ESD many- outliers procedure. Technometrics 25:165–172. Schulz WA, Steinhoff C, Florl AR. 2006. Methylation of endog- enous human retroelements in health and disease. Curr Top Microbiol Immunol 310:211–250. Sciandrello G, Caradonna F, Mauro M, Barbata G. 2004. Arsenic- induced DNA hypomethylation affects chromosomal insta- bility in mammalian cells. Carcinogenesis 25:413–417. Takiguchi M, Achanzar WE, Qu W, Li G, Waalkes MP. 2003. Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium- induced cellular transformation. Exp Cell Res 286:355–365. Tarantini L, Bonzini M, Apostoli P, Pegoraro V, Bollati V, Marinelli B, et al. 2009. Effects of particulate matter on genomic DNA methylation content and iNOS promoter methylation. Environ Health Perspect 117:217–222. Todd AC, Chettle DR. 1994. In vivo X-ray fluorescence of lead in bone: review and current issues. Environ Health Perspect 102:172–177. Tost J, Dunker J, Gut IG. 2003. Analysis and quantification of multiple methylation variable positions in CpG islands by pyrosequencing. Biotechniques 35:152–156. Turk PW, Laayoun A, Smith SS, Weitzman SA. 1995. DNA adduct 8-hydroxyl-2’-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 16:1253–1255. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. 2004. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 32:4100–4108. Valko M, Morris H, Cronin MT. 2005. Metals, toxicity and oxidative stress. Curr Med Chem 12:1161–1208. Wallace N, Wagstaff BJ, Deininger PL, Roy-Engel AM. 2008a. LINE-1 ORF1 protein enhances Alu SINE retrotransposition. Gene 419(1–2):1–6. Wallace NA, Belancio VP, Deininger PL. 2008b. L1 mobile ele- ment expression causes multiple types of toxicity. Gene 419(1–2):75–81. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, et al. 2005. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33(21):6823–6836. Whitsel EA, Boyko EJ, Matsumoto AM, Anawalt BD, Siscovick DS. 2001. Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Am J Med 111:261–269. Wilson AS, Power BE, Molloy PL. 2007. DNA hypomethylation and human diseases. Biochim Biophys Acta 1775:138–162. Yang AS, Estécio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. 2004. A simple method for estimating global DNA methyla- tion using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32:e38. Zemojtel T, Penzkofer T, Schultz J, Dandekar T, Badge R, Vingron M. 2007. Exonization of active mouse L1s: a driver of transcriptome evolution? BMC Genomics 8:392 doi:10.1186/1471-2164-8-392 [Online 26 October 2007]. Environmental Health Perspectives • volume 118 | number 6 | June 2010 795